2024년에 120억 달러로 추정되는 질병 관리 앱 세계 시장은 2024년부터 2030년까지 13.2%의 CAGR로 성장하여 2030년에는 253억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 iOS 플랫폼은 CAGR 12.4%를 기록하며 분석 기간 종료시에는 145억 달러에 달할 것으로 예측됩니다. Android 플랫폼 부문의 성장률은 분석 기간 CAGR로 14.9%로 추정됩니다.
미국 시장은 32억 달러, 중국은 CAGR 12.4%로 성장할 것으로 예측
미국의 질병 관리 앱 시장은 2024년에 32억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 39억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 12.4%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 12.0%와 11.4%로 예측됩니다. 유럽에서는 독일이 CAGR 약 9.7%로 성장할 것으로 예측됩니다.
세계 질병 관리 앱 시장 - 주요 동향 및 촉진요인 정리
디지털 헬스 기술이 질병 관리를 재구성하다?
디지털 헬스 기술의 급속한 도입은 실시간 환자 모니터링, 맞춤형 치료 계획, 의료 서비스 접근성 향상 등 질병 관리에 변화를 가져오고 있습니다. 질병 관리 앱은 이러한 혁명의 최전선에 있으며, 환자가 증상, 약물 순응도, 생활습관 개선을 추적하는 데 도움이 되는 모바일 및 클라우드 기반 플랫폼을 제공하고 있습니다. 이 앱들은 웨어러블 기기, 전자 의료 기록(EHR), AI 기반 분석과 통합되어 의료 전문가에게 사전 예방적 치료를 위한 귀중한 인사이트를 제공합니다. 당뇨병, 고혈압, 심혈관질환과 같은 만성질환은 환자가 자신의 상태를 스스로 관리할 수 있는 편리한 도구를 원하기 때문에 앱 도입의 주요 촉진요인으로 작용하고 있습니다. 그러나 데이터 프라이버시, 규제 준수, 디지털 리터러시에 대한 우려는 여전히 과제로 남아있습니다. 이러한 장애물에도 불구하고, 질병 관리 앱은 환자와 의료진 모두에게 필수적인 도구가 되고 있으며, 기술 기반 솔루션을 통해 만성질환 관리에 혁명을 일으키고 있습니다.
AI와 머신러닝은 어떻게 질병 모니터링을 강화하는가?
인공지능(AI)과 머신러닝(ML)은 예측 분석, 자동 건강 코칭, 개인화된 추천을 가능하게 하는 등 질병 관리 앱 개선에 중요한 역할을 하고 있습니다. AI 기반 알고리즘은 환자 데이터를 분석하여 조기 경보 징후를 식별하고 적시에 개입하여 질병의 합병증을 예방할 수 있도록 돕습니다. 챗봇과 가상 비서는 즉각적인 지원, 복약 알림, 생활습관 추천을 제공함으로써 환자 참여를 강화하고 있습니다. 또한, AI 기반 증상 검사기는 사용자가 의사와 상담하기 전에 건강 상태를 평가할 수 있도록 돕고 있습니다. 이러한 발전에도 불구하고 알고리즘의 편향성, 데이터 보안 위험, 규제 당국의 승인 절차 등의 문제가 AI의 보급을 가로막고 있습니다. 그러나 AI 기술이 성숙해짐에 따라 질병 관리 앱에서 AI의 역할이 확대되어 의료 서비스를 보다 예측적이고, 데이터 기반적이며, 접근하기 쉽게 만들 수 있을 것으로 기대됩니다.
질병 관리 앱이 원격 환자 모니터링과 원격의료를 개선할 수 있을까?
원격의료와 원격 환자 모니터링의 부상으로 질병 관리 앱에 대한 수요가 급증하고 있습니다. 의료 서비스 제공자는 임상 현장 밖에서 환자를 관리할 수 있는 효율적인 방법을 모색하고 있기 때문입니다. 이 앱을 통해 의사는 환자의 경과를 추적하고, 실시간 건강 상태 업데이트를 받고, 지속적인 모니터링 데이터를 기반으로 치료 계획을 조정할 수 있습니다. 천식, 관절염, 정신질환과 같은 만성질환을 원격으로 관리함으로써 병원 방문을 줄이고, 의료시스템의 부담을 줄이며, 환자의 예후를 개선하고 있습니다. 또한, 모바일 헬스(모바일 헬스) 애플리케이션은 수술 후 회복, 재활, 완화의료 관리에서 중요한 역할을 하고 있습니다. 그러나 인터넷 접근성 및 디지털 헬스 리터러시 격차는 공평한 도입을 위해 반드시 해결해야 할 과제입니다. 헬스케어가 가치 기반 케어 모델로 전환하는 가운데, 질병 관리 앱은 원격지에서도 환자 중심의 지속적인 의료 서비스를 제공할 수 있는 필수적인 도구가 될 것으로 기대됩니다.
질병 관리 앱 시장의 성장 원동력은?
질병 관리 앱 시장의 성장은 만성질환의 증가, AI를 활용한 헬스케어 분석의 발전, 원격의료 서비스의 확대 등 여러 요인에 의해 이루어지고 있습니다. 원격 환자 모니터링 및 디지털 헬스 솔루션에 대한 수요 증가는 특히 탄탄한 의료 인프라를 갖춘 신흥국 시장에서 앱 채택을 더욱 가속화하고 있습니다. 또한, 헬스케어 스타트업과 디지털 치료제(DTx)에 대한 투자 증가는 질병 관리 애플리케이션의 기술 혁신을 촉진하고 있습니다. 디지털 헬스케어를 장려하는 정부의 노력은 모바일 헬스케어 솔루션에 대한 유리한 상환 정책과 함께 시장 성장을 촉진하고 있습니다. 데이터 프라이버시 문제, 규제 준수, 기술 격차 등의 과제는 여전히 남아 있지만, AI, 클라우드 컴퓨팅, 모바일 헬스 분야의 지속적인 발전은 질병 관리 앱 시장을 발전시키고 디지털 질병 관리를 현대 의료의 표준 구성요소로 만들 것으로 예상됩니다.
부문
플랫폼(iOS 플랫폼, Android 플랫폼, 기타 플랫폼), 디바이스(스마트폰, 태블릿, 웨어러블 디바이스), 적응증(비만, 심혈관질환, 정신건강, 당뇨병, 기타 적응증)
조사 대상 기업 사례
Acronis International GmbH
Arcserve LLC
Axcient Inc.
Carbonite, Inc.
Cohesity Inc.
Datto, a Kaseya Company
Dell Technologies Inc.
IBM Corporation
Microsoft Corporation
N-able Technologies Ltd.
Oracle Corporation
Quorum Labs, Inc.
Rubrik, Inc.
StorageCraft Technology Corporation
Unitrends, a Kaseya Company
Veeam Software Group
Veritas Technologies LLC
VMware, Inc.
Zerto, a Hewlett Packard Enterprise Company
AI 통합
우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.
Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
KSM
영문 목차
영문목차
Global Disease Management Apps Market to Reach US$25.3 Billion by 2030
The global market for Disease Management Apps estimated at US$12.0 Billion in the year 2024, is expected to reach US$25.3 Billion by 2030, growing at a CAGR of 13.2% over the analysis period 2024-2030. iOS Platform, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$14.5 Billion by the end of the analysis period. Growth in the Android Platform segment is estimated at 14.9% CAGR over the analysis period.
The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 12.4% CAGR
The Disease Management Apps market in the U.S. is estimated at US$3.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 12.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.
Are Digital Health Technologies Reshaping Disease Management?
The rapid adoption of digital health technologies is transforming disease management, enabling real-time patient monitoring, personalized treatment plans, and enhanced healthcare accessibility. Disease management apps are at the forefront of this revolution, offering mobile and cloud-based platforms that help patients track symptoms, medication adherence, and lifestyle modifications. These apps integrate with wearable devices, electronic health records (EHRs), and AI-driven analytics, providing healthcare professionals with valuable insights for proactive care. Chronic diseases such as diabetes, hypertension, and cardiovascular disorders are major drivers of app adoption, as patients seek convenient tools to self-manage their conditions. However, concerns over data privacy, regulatory compliance, and digital literacy continue to pose challenges. Despite these hurdles, disease management apps are becoming indispensable tools for both patients and healthcare providers, revolutionizing chronic disease care through technology-driven solutions.
How Is AI and Machine Learning Enhancing Disease Monitoring?
Artificial intelligence (AI) and machine learning (ML) are playing a crucial role in improving disease management apps, enabling predictive analytics, automated health coaching, and personalized recommendations. AI-powered algorithms analyze patient data to identify early warning signs, allowing for timely intervention and preventing disease complications. Chatbots and virtual health assistants are enhancing patient engagement by providing instant support, medication reminders, and lifestyle recommendations. Additionally, AI-driven symptom checkers are helping users assess their health conditions before consulting a physician. Despite these advancements, challenges such as algorithm biases, data security risks, and regulatory approval processes remain barriers to widespread AI integration. However, as AI technology matures, its role in disease management apps is expected to expand, making healthcare more predictive, data-driven, and accessible.
Can Disease Management Apps Improve Remote Patient Monitoring and Telemedicine?
The rise of telemedicine and remote patient monitoring is fueling the demand for disease management apps, as healthcare providers seek efficient ways to manage patients outside clinical settings. These apps enable doctors to track patient progress, receive real-time health updates, and adjust treatment plans based on continuous monitoring data. Remote management of chronic conditions such as asthma, arthritis, and mental health disorders is reducing hospital visits, easing the burden on healthcare systems, and improving patient outcomes. Additionally, mobile health (mHealth) applications are playing a key role in managing post-operative recovery, rehabilitation, and palliative care. However, disparities in internet access and digital health literacy are challenges that must be addressed for equitable adoption. As healthcare shifts toward value-based care models, disease management apps are expected to become essential tools in enabling remote, continuous, and patient-centric healthcare delivery.
What Is Driving the Growth of the Disease Management Apps Market?
The growth in the disease management apps market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in AI-powered healthcare analytics, and the expansion of telemedicine services. The rising demand for remote patient monitoring and digital health solutions is further accelerating app adoption, particularly in developed markets with robust healthcare infrastructure. Additionally, growing investments in health tech startups and digital therapeutics (DTx) are driving innovation in disease management applications. Government initiatives promoting digital healthcare, coupled with favorable reimbursement policies for mobile health solutions, are also boosting market growth. While challenges such as data privacy concerns, regulatory compliance, and technological disparities persist, continued advancements in AI, cloud computing, and mobile health are expected to propel the disease management apps market forward, making digital disease management a standard component of modern healthcare.
SCOPE OF STUDY:
The report analyzes the Disease Management Apps market in terms of units by the following Segments, and Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 43 Featured) -
Acronis International GmbH
Arcserve LLC
Axcient Inc.
Carbonite, Inc.
Cohesity Inc.
Datto, a Kaseya Company
Dell Technologies Inc.
IBM Corporation
Microsoft Corporation
N-able Technologies Ltd.
Oracle Corporation
Quorum Labs, Inc.
Rubrik, Inc.
StorageCraft Technology Corporation
Unitrends, a Kaseya Company
Veeam Software Group
Veritas Technologies LLC
VMware, Inc.
Zerto, a Hewlett Packard Enterprise Company
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Disease Management Apps - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Chronic Diseases Drives Increased Adoption of Disease Management Apps for Remote Monitoring
Surge in Healthcare Digitization and Telemedicine Expands the Addressable Market for Disease Management Applications
Growing Consumer Preference for Self-Management Tools Accelerates Demand for Mobile Disease Management Apps
Technological Advancements in Wearables and IoT Devices Strengthen the Integration of Disease Management Apps with Real-Time Data
Regulatory Push for Better Healthcare Accessibility and Patient-Centric Care Propels Growth in Disease Management App Market
Increasing Focus on Preventive Healthcare and Early Intervention Strengthens the Adoption of Disease Management Solutions
Surge in Healthcare Insurance Providers Offering Digital Tools Expands the Reach and Adoption of Disease Management Apps
Rising Interest in Personalized Medicine and Tailored Treatment Plans Drives the Demand for Customized Disease Management Applications
Growth in Digital Health Funding and Investment Expands the Innovation Potential and Market Reach of Disease Management Apps
The Need for Efficient Chronic Disease Monitoring and Compliance Drives Demand for Disease Management Apps in Home Healthcare
Integration of AI and Machine Learning in Disease Management Apps Improves Diagnostic Accuracy and Treatment Recommendations
The Shift Toward Value-Based Healthcare Models Accelerates the Adoption of Disease Management Apps for Better Patient Outcomes
Increasing Incidence of Mental Health Disorders and Stress-Related Conditions Drives Growth in Disease Management Apps for Mental Health
Surge in Use of Mobile Health (mHealth) Apps to Manage Non-Communicable Diseases Expands Market Opportunities for Disease Management Apps
Growing Focus on Mobile-Based Disease Tracking Tools for Maternal and Child Health Strengthens Demand in Global Health Markets
Expansion of Chronic Care Management Programs in Developed and Developing Economies Drives Global Adoption of Disease Management Apps
The Rise in Social Media and Health Communities Drives Consumer Education and Adoption of Disease Management Apps
Increasing Integration of Disease Management Apps with Electronic Health Records (EHR) Systems Improves Coordination of Care
Growing Awareness of Health Data Privacy and Security Strengthens Trust and Adoption of Secure Disease Management Platforms
Surge in Healthcare Reform and Policies Supporting Digital Health Tools Drives Market Growth for Disease Management Solutions
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Disease Management Apps Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Disease Management Apps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Disease Management Apps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Disease Management Apps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for iOS Platform by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for iOS Platform by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for iOS Platform by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Android Platform by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Android Platform by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Android Platform by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Other Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Other Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Other Platforms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Cardiovascular Issues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Cardiovascular Issues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Cardiovascular Issues by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Mental Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Mental Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Mental Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Smartphones by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Smartphones by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Smartphones by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Tablets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Wearable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Wearable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for Wearable Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: USA Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: USA 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: USA Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: USA 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: USA Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: USA 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: Canada 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: Canada 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: Canada 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
JAPAN
Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 56: Japan Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Japan 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Japan 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Japan 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
CHINA
Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 65: China Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: China Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: China 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: China Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: China 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 71: China Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: China Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: China 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
EUROPE
Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 74: Europe Recent Past, Current & Future Analysis for Disease Management Apps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Disease Management Apps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: Europe 15-Year Perspective for Disease Management Apps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: Europe 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Europe 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Europe 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
FRANCE
Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 86: France Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: France Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: France 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: France Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: France 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: France Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: France 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
GERMANY
Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 95: Germany Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: Germany 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: Germany 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 101: Germany Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Germany 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
ITALY
TABLE 104: Italy Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Italy 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Italy 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 110: Italy Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: Italy 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
UNITED KINGDOM
Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 113: UK Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: UK Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: UK 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: UK Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: UK 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 119: UK Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: UK Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: UK 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: Rest of Europe Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: Rest of Europe 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: Rest of Europe Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: Rest of Europe 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: Rest of Europe Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: Rest of Europe 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Asia-Pacific Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: Asia-Pacific 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Asia-Pacific Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: Asia-Pacific 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Asia-Pacific Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: Asia-Pacific 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
REST OF WORLD
TABLE 140: Rest of World Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Rest of World Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: Rest of World 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
TABLE 143: Rest of World Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Rest of World Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: Rest of World 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
TABLE 146: Rest of World Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Rest of World Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: Rest of World 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
